Arcus Biosciences (RCUS) Enterprise Value Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Arcus Biosciences | 3.18 Bn | 2.36 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.55% |
| Dec 31, 2025 | -0.31% |
| Sep 30, 2025 | 23.69% |
| Jun 30, 2025 | 5.99% |
| Mar 31, 2025 | -0.20% |
| Dec 31, 2024 | -28.85% |
| Sep 30, 2024 | -36.30% |
| Jun 30, 2024 | -4.19% |
| Mar 31, 2024 | -4.30% |
| Dec 31, 2023 | 24.78% |
| Sep 30, 2023 | 23.84% |
| Jun 30, 2023 | 20.73% |
| Mar 31, 2023 | 21.40% |
| Dec 31, 2022 | -102.20% |
| Sep 30, 2022 | -99.97% |
| Jun 30, 2022 | -62.71% |
| Mar 31, 2022 | -46.78% |
| Dec 31, 2021 | 31.52% |
| Sep 30, 2021 | 32.95% |
| Jun 30, 2021 | -55.90% |
| Mar 31, 2021 | -423.82% |
| Dec 31, 2020 | -287.02% |
| Sep 30, 2020 | -309.67% |
| Jun 30, 2020 | -106.09% |
| Mar 31, 2020 | 34.75% |
| Dec 31, 2019 | 26.61% |
| Sep 30, 2019 | 25.93% |
| Jun 30, 2019 | 15.54% |
| Mar 31, 2019 | 13.65% |
| Dec 31, 2018 | -46.01% |
| Sep 30, 2018 | -1,308.48% |
| Jun 30, 2018 | -797.02% |
| Mar 31, 2018 | -616.59% |
| Dec 31, 2017 | -169.65% |